首页 > 最新文献

Case Reports in Dermatological Medicine最新文献

英文 中文
Fluconazole-Induced Fixed Drug Eruption With Cross-Reactivity to Clotrimazole-Confirmation With Patch Testing. 氟康唑致与氯霉唑交叉反应的固定药疹——用斑贴试验证实。
Q3 Medicine Pub Date : 2026-01-28 eCollection Date: 2026-01-01 DOI: 10.1155/crdm/1152541
D S Sron, P Martinez, J Iacobelli, P Singh, B M Ricciardo

First described in 1994, fixed drug eruption (FDE) to fluconazole is uncommon but possibly underdiagnosed. Of these, women with vaginal candidiasis remain the most affected, with on average more than four occurrences prior to diagnosis. We present a case of a 29-year-old female who presented after her third episode of an itchy, oedematous, blistering rash on her right hand that developed 2 h following ingestion of 150 mg of fluconazole. She reported two similar episodes in the 2 years prior, all following administration of fluconazole for vaginal candidiasis. Each episode resulted in a rash localized to her right hand, with each subsequent exposure resulting in faster onset of symptoms and signs. A FDE to fluconazole was suspected clinically, and lesional skin biopsies were consistent with this. The diagnosis was confirmed with a positive patch test to 5% fluconazole applied to the affected skin on the right hand. Cross-reactivity with clotrimazole was confirmed with a positive patch test to clotrimazole 5%. She was subsequently advised to avoid both fluconazole and clotrimazole. Although cross-reactivity between different azole antifungal agents has been described, cross-reactivity between fluconazole and clotrimazole is a novel finding. This case raises awareness of FDE to fluconazole, in particular for women being treated for vaginal candidiasis, and highlights the importance of patch testing to other antifungal agents to assess for cross-reactivity.

氟康唑引起的固定药疹(FDE)于1994年首次报道,并不常见,但可能未被充分诊断。其中,患有阴道念珠菌病的妇女仍然是受影响最大的,在诊断前平均发生四次以上。我们提出一个病例29岁的女性谁提出后,她的第三次发痒,水肿,起泡皮疹在她的右手,在摄入氟康唑150mg 2小时后发展。她在2年前报告了两次类似的发作,均在服用氟康唑治疗阴道念珠菌病之后。每次发作都导致她的右手出现局部皮疹,随后每次接触都会导致症状和体征发作更快。临床怀疑氟康唑中毒,病变皮肤活检与此一致。在右手受影响的皮肤上应用5%氟康唑贴片试验阳性,证实了诊断。对5%氯霉唑进行膜片试验,证实与氯霉唑有交叉反应。随后建议她避免使用氟康唑和克霉唑。虽然不同的唑类抗真菌药物之间的交叉反应性已经被描述过,但氟康唑和克霉唑之间的交叉反应性是一个新的发现。该病例提高了对氟康唑的FDE的认识,特别是对正在接受阴道念珠菌病治疗的妇女,并强调了对其他抗真菌药物进行贴片试验以评估交叉反应性的重要性。
{"title":"Fluconazole-Induced Fixed Drug Eruption With Cross-Reactivity to Clotrimazole-Confirmation With Patch Testing.","authors":"D S Sron, P Martinez, J Iacobelli, P Singh, B M Ricciardo","doi":"10.1155/crdm/1152541","DOIUrl":"10.1155/crdm/1152541","url":null,"abstract":"<p><p>First described in 1994, fixed drug eruption (FDE) to fluconazole is uncommon but possibly underdiagnosed. Of these, women with vaginal candidiasis remain the most affected, with on average more than four occurrences prior to diagnosis. We present a case of a 29-year-old female who presented after her third episode of an itchy, oedematous, blistering rash on her right hand that developed 2 h following ingestion of 150 mg of fluconazole. She reported two similar episodes in the 2 years prior, all following administration of fluconazole for vaginal candidiasis. Each episode resulted in a rash localized to her right hand, with each subsequent exposure resulting in faster onset of symptoms and signs. A FDE to fluconazole was suspected clinically, and lesional skin biopsies were consistent with this. The diagnosis was confirmed with a positive patch test to 5% fluconazole applied to the affected skin on the right hand. Cross-reactivity with clotrimazole was confirmed with a positive patch test to clotrimazole 5%. She was subsequently advised to avoid both fluconazole and clotrimazole. Although cross-reactivity between different azole antifungal agents has been described, cross-reactivity between fluconazole and clotrimazole is a novel finding. This case raises awareness of FDE to fluconazole, in particular for women being treated for vaginal candidiasis, and highlights the importance of patch testing to other antifungal agents to assess for cross-reactivity.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2026 ","pages":"1152541"},"PeriodicalIF":0.0,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146084337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A CLIP on the Ear: Spitz Melanocytoma Harbouring a CLIP2-BRAF Gene Fusion. 耳朵上的CLIP: Spitz黑色素细胞瘤携带CLIP2-BRAF基因融合。
Q3 Medicine Pub Date : 2026-01-27 eCollection Date: 2026-01-01 DOI: 10.1155/crdm/1460562
Karwan A Moutasim, Mohammed Atweh, Jeffery M Theaker

Spitzoid lesions represent one of the most challenging areas in melanocytic pathology. Many such lesions are characterised by key gene alterations including ALK, ROS and NTRK fusions. BRAF mutations are generally considered incompatible with the diagnosis of Spitz tumours. Here, we present the case of a spitzoid melanocytoma harbouring a rare BRAF gene fusion. A brief overview of the literature is also touched upon.

Spitzoid病变是黑素细胞病理学中最具挑战性的领域之一。许多此类病变的特征是关键基因改变,包括ALK、ROS和NTRK融合。BRAF突变通常被认为与Spitz肿瘤的诊断不相容。在这里,我们提出一个spitzoid黑素细胞瘤窝藏一个罕见的BRAF基因融合。文献的简要概述也触及。
{"title":"A <i>CLIP</i> on the Ear: Spitz Melanocytoma Harbouring a <i>CLIP2-BRAF</i> Gene Fusion.","authors":"Karwan A Moutasim, Mohammed Atweh, Jeffery M Theaker","doi":"10.1155/crdm/1460562","DOIUrl":"https://doi.org/10.1155/crdm/1460562","url":null,"abstract":"<p><p>Spitzoid lesions represent one of the most challenging areas in melanocytic pathology. Many such lesions are characterised by key gene alterations including <i>ALK, ROS</i> and <i>NTRK</i> fusions. <i>BRAF</i> mutations are generally considered incompatible with the diagnosis of Spitz tumours. Here, we present the case of a spitzoid melanocytoma harbouring a rare <i>BRAF</i> gene fusion. A brief overview of the literature is also touched upon.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2026 ","pages":"1460562"},"PeriodicalIF":0.0,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complex Dermatological Manifestations of Poorly Controlled Diabetes: A Case of Acquired Ichthyosis. 糖尿病控制不良的复杂皮肤病学表现:一例获得性鱼鳞病。
Q3 Medicine Pub Date : 2026-01-27 eCollection Date: 2026-01-01 DOI: 10.1155/crdm/4532886
Sam Fathizadeh, Alexander D Woods, Saul Turcios Escobar, Maria Tsoukas

Acquired ichthyosis (AI) is a rare dermatological disorder characterized by dry, scaly skin. This case involves a 67-year-old Hispanic male with poorly controlled diabetes mellitus (DM) who presented with generalized dryness and itchiness after diabetic ketoacidosis. Examination revealed polygonal scales with erythema, and biopsy confirmed AI. Laboratory tests showed elevated glucose, dyslipidemia, hyponatremia, hyperkalemia, and Stage IIIb chronic kidney disease. Treatment included moisturizers, antihistamines, antifungal shampoo, topical corticosteroids, tacrolimus, and optimized DM management, leading to improvement. AI is often linked to systemic conditions like malignancy, autoimmune diseases, infections, and certain medications. Diagnosis is clinical and biopsy-supported, requiring a systemic workup to identify underlying causes. Poorly controlled DM was significant in this case, highlighting the importance of comprehensive assessment. Early recognition and understanding of AI's association with DM can optimize treatment and reduce morbidity.

获得性鱼鳞病(AI)是一种罕见的皮肤病,其特征是皮肤干燥,鳞状。本病例涉及一名67岁西班牙裔男性,糖尿病控制不佳,糖尿病酮症酸中毒后出现全身干燥和瘙痒。检查显示多角形鳞片伴红斑,活检证实AI。实验室检查显示血糖升高、血脂异常、低钠血症、高钾血症和IIIb期慢性肾病。治疗包括保湿剂、抗组胺药、抗真菌洗发水、局部皮质类固醇、他克莫司和优化的糖尿病管理,导致改善。人工智能通常与恶性肿瘤、自身免疫性疾病、感染和某些药物等系统性疾病有关。诊断是临床和活检支持,需要系统的检查,以确定潜在的原因。在这种情况下,控制不良的糖尿病是显著的,突出了综合评估的重要性。早期识别和了解人工智能与糖尿病的关系可以优化治疗并降低发病率。
{"title":"Complex Dermatological Manifestations of Poorly Controlled Diabetes: A Case of Acquired Ichthyosis.","authors":"Sam Fathizadeh, Alexander D Woods, Saul Turcios Escobar, Maria Tsoukas","doi":"10.1155/crdm/4532886","DOIUrl":"https://doi.org/10.1155/crdm/4532886","url":null,"abstract":"<p><p>Acquired ichthyosis (AI) is a rare dermatological disorder characterized by dry, scaly skin. This case involves a 67-year-old Hispanic male with poorly controlled diabetes mellitus (DM) who presented with generalized dryness and itchiness after diabetic ketoacidosis. Examination revealed polygonal scales with erythema, and biopsy confirmed AI. Laboratory tests showed elevated glucose, dyslipidemia, hyponatremia, hyperkalemia, and Stage IIIb chronic kidney disease. Treatment included moisturizers, antihistamines, antifungal shampoo, topical corticosteroids, tacrolimus, and optimized DM management, leading to improvement. AI is often linked to systemic conditions like malignancy, autoimmune diseases, infections, and certain medications. Diagnosis is clinical and biopsy-supported, requiring a systemic workup to identify underlying causes. Poorly controlled DM was significant in this case, highlighting the importance of comprehensive assessment. Early recognition and understanding of AI's association with DM can optimize treatment and reduce morbidity.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2026 ","pages":"4532886"},"PeriodicalIF":0.0,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12838225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stage IV SMARCA4-Deficient Undifferentiated Malignant Neoplasm With Primary Cutaneous Origin and Early Distant Metastases. 伴有原发性皮肤起源和早期远处转移的IV期smarca4缺陷未分化恶性肿瘤。
Q3 Medicine Pub Date : 2026-01-16 eCollection Date: 2026-01-01 DOI: 10.1155/crdm/9982655
Katlyn M Smaha, Matthew Willett, David E Kent

SMARCA4-deficient undifferentiated malignant neoplasms (SD-UMNs) are a recently recognized group of malignant epithelioid tumors, associated with mutations in the SWItch/Sucrose nonfermentable chromatin remodeling complex. To our knowledge, there have been only three cases of SD-UMNs primary to the skin. We report a rare case of primary cutaneous SD-UMN in an 85-year-old male with a former 25-pack-year smoking history. Unlike previous cases, he notably was diagnosed as Stage IV upon presentation, with metastatic involvement of lymph nodes and liver. Our case highlights the importance of recognizing SD-UMN from other types of poorly differentiated cutaneous epithelioid malignant neoplasms, given its aggressive nature and potential for targeted therapies. It also adds to the growing but still limited understanding of the clinical and histopathological features of this rare malignancy.

缺乏smarca4的未分化恶性肿瘤(SD-UMNs)是最近发现的一类恶性上皮样肿瘤,与SWItch/蔗糖不可发酵染色质重塑复合体的突变有关。据我们所知,只有3例sd - umn原发于皮肤。我们报告一例罕见的原发性皮肤SD-UMN病例,患者为85岁男性,既往吸烟25年。与以往的病例不同,他在就诊时被诊断为IV期,淋巴结和肝脏转移。我们的病例强调了从其他类型的低分化皮肤上皮样恶性肿瘤中识别SD-UMN的重要性,因为它具有侵袭性和靶向治疗的潜力。它也增加了对这种罕见恶性肿瘤的临床和组织病理学特征的不断增长但仍然有限的理解。
{"title":"Stage IV SMARCA4-Deficient Undifferentiated Malignant Neoplasm With Primary Cutaneous Origin and Early Distant Metastases.","authors":"Katlyn M Smaha, Matthew Willett, David E Kent","doi":"10.1155/crdm/9982655","DOIUrl":"10.1155/crdm/9982655","url":null,"abstract":"<p><p>SMARCA4-deficient undifferentiated malignant neoplasms (SD-UMNs) are a recently recognized group of malignant epithelioid tumors, associated with mutations in the SWItch/Sucrose nonfermentable chromatin remodeling complex. To our knowledge, there have been only three cases of SD-UMNs primary to the skin. We report a rare case of primary cutaneous SD-UMN in an 85-year-old male with a former 25-pack-year smoking history. Unlike previous cases, he notably was diagnosed as Stage IV upon presentation, with metastatic involvement of lymph nodes and liver. Our case highlights the importance of recognizing SD-UMN from other types of poorly differentiated cutaneous epithelioid malignant neoplasms, given its aggressive nature and potential for targeted therapies. It also adds to the growing but still limited understanding of the clinical and histopathological features of this rare malignancy.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2026 ","pages":"9982655"},"PeriodicalIF":0.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12809176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-Induced Fuchs Syndrome With Isolated Oral Involvement: A Rare Case Report. 药物引起的富克斯综合征伴孤立性口腔受累:一例罕见病例报告。
Q3 Medicine Pub Date : 2026-01-15 eCollection Date: 2026-01-01 DOI: 10.1155/crdm/9455957
Salina Paudel, Manoj Kumar Bhatt, Shiv Kumar Chaudhary, Sandhya Silwal, Abinash Parajuli, Pramod Kumar Kafle

Stevens-Johnson syndrome (SJS) is a rare, potentially life-threatening mucocutaneous disorder characterized by epidermal necrosis and mucosal bullous lesions involving less than 10% of the total body surface area. The majority of cases are aggravated by delayed hypersensitivity reactions to medications. An uncommon presentation of SJS is isolated mucosal involvement without skin lesions, referred to as "Fuchs syndrome." This variant is most frequently linked to Mycoplasma pneumoniae infection and certain drugs, and it often poses a diagnostic challenge due to its similarity with other mucosal pathologies. We report a case of a 6-year-old boy who developed isolated oral lesions following amoxicillin therapy. Prompt identification and supportive management led to complete recovery. This case emphasizes the importance of early recognition and intervention in atypical presentations of SJS.

史蒂文斯-约翰逊综合征(SJS)是一种罕见的、可能危及生命的粘膜皮肤疾病,其特征是表皮坏死和粘膜大疱病变占体表总面积不到10%。大多数病例因对药物的延迟性超敏反应而加重。一种罕见的SJS表现是孤立的粘膜受累而无皮肤损害,称为“Fuchs综合征”。这种变异最常与肺炎支原体感染和某些药物有关,并且由于其与其他粘膜病理的相似性,通常构成诊断挑战。我们报告一个病例6岁男孩谁发展孤立的口腔病变后阿莫西林治疗。及时的识别和支持性管理使患者完全康复。这个病例强调了早期识别和干预非典型SJS的重要性。
{"title":"Drug-Induced Fuchs Syndrome With Isolated Oral Involvement: A Rare Case Report.","authors":"Salina Paudel, Manoj Kumar Bhatt, Shiv Kumar Chaudhary, Sandhya Silwal, Abinash Parajuli, Pramod Kumar Kafle","doi":"10.1155/crdm/9455957","DOIUrl":"10.1155/crdm/9455957","url":null,"abstract":"<p><p>Stevens-Johnson syndrome (SJS) is a rare, potentially life-threatening mucocutaneous disorder characterized by epidermal necrosis and mucosal bullous lesions involving less than 10% of the total body surface area. The majority of cases are aggravated by delayed hypersensitivity reactions to medications. An uncommon presentation of SJS is isolated mucosal involvement without skin lesions, referred to as \"Fuchs syndrome.\" This variant is most frequently linked to Mycoplasma pneumoniae infection and certain drugs, and it often poses a diagnostic challenge due to its similarity with other mucosal pathologies. We report a case of a 6-year-old boy who developed isolated oral lesions following amoxicillin therapy. Prompt identification and supportive management led to complete recovery. This case emphasizes the importance of early recognition and intervention in atypical presentations of SJS.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2026 ","pages":"9455957"},"PeriodicalIF":0.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12807583/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two Cases of Allergic Contact Dermatitis Caused by Coco Betaine in Clobetasol Propionate Shampoo. 丙酸氯倍他索香波中椰碱致过敏性接触性皮炎2例。
Q3 Medicine Pub Date : 2026-01-02 eCollection Date: 2026-01-01 DOI: 10.1155/crdm/9953943
Shigeruko Iijima, Kayo Murayama, Noriko Takayama, Mariko Sugiyama, Kayoko Matsunaga

We present two cases of allergic contact dermatitis caused by the amphoteric surfactant coco betaine, a constituent of clobetasol propionate (CP) shampoo, despite the low allergenic potential of CP shampoo formulations. The patients were Japanese males, aged 49 and 52 years, with severe atopic dermatitis, who had been treated with oral cyclosporine for several years. Patch testing revealed that only coco betaine 1% aq. showed a clearly positive reaction in both cases, whereas the patch test results of CP shampoo, cocamidopropyl betaine, and lauramidopropyl betaine were positive in one case and doubtful in the other. In cases of recalcitrant scalp dermatitis, it is necessary to consider the possibility that it is being caused by the topical medication used to treat it, and that the "active" ingredient may not be the culprit.

我们提出了两例过敏性接触性皮炎由两性表面活性剂椰甜菜碱引起的,椰甜菜碱是丙酸氯倍他索(CP)洗发水的一种成分,尽管CP洗发水配方的致敏性很低。患者为日本男性,年龄49岁至52岁,患有严重特应性皮炎,口服环孢素治疗数年。斑贴试验结果显示,只有可可甜菜碱1%水溶液在两种情况下均有明显的阳性反应,而CP洗发水、椰油酰胺丙基甜菜碱和月桂酰胺丙基甜菜碱的斑贴试验结果均为阳性,另一例为可疑。在顽固头皮皮炎的情况下,有必要考虑它是由用于治疗它的局部药物引起的可能性,而“活性”成分可能不是罪魁祸首。
{"title":"Two Cases of Allergic Contact Dermatitis Caused by Coco Betaine in Clobetasol Propionate Shampoo.","authors":"Shigeruko Iijima, Kayo Murayama, Noriko Takayama, Mariko Sugiyama, Kayoko Matsunaga","doi":"10.1155/crdm/9953943","DOIUrl":"10.1155/crdm/9953943","url":null,"abstract":"<p><p>We present two cases of allergic contact dermatitis caused by the amphoteric surfactant coco betaine, a constituent of clobetasol propionate (CP) shampoo, despite the low allergenic potential of CP shampoo formulations. The patients were Japanese males, aged 49 and 52 years, with severe atopic dermatitis, who had been treated with oral cyclosporine for several years. Patch testing revealed that only coco betaine 1% aq. showed a clearly positive reaction in both cases, whereas the patch test results of CP shampoo, cocamidopropyl betaine, and lauramidopropyl betaine were positive in one case and doubtful in the other. In cases of recalcitrant scalp dermatitis, it is necessary to consider the possibility that it is being caused by the topical medication used to treat it, and that the \"active\" ingredient may not be the culprit.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2026 ","pages":"9953943"},"PeriodicalIF":0.0,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12759260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145899216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytokeratin 20-Negative Merkel Cell Carcinoma: A Case Series and Discussion of Diagnostic Strategies. 细胞角蛋白20阴性的默克尔细胞癌:病例系列和诊断策略的讨论。
Q3 Medicine Pub Date : 2025-12-29 eCollection Date: 2025-01-01 DOI: 10.1155/crdm/8439328
Ryan H Wealther, Kritin K Verma, Ethan Matthew, Helen Chen, Cloyce Stetson

Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine carcinoma of the skin. MCC can present a diagnostic challenge, especially in cases where Cytokeratin 20 (CK20) is negative or focally positive. CK20-negative MCC accounts for about 5% of MCCs. This case series describes five cases of CK20-negative or focally positive MCC at an academic medical center. All cases were biopsies of cutaneous lesions. Histopathological investigation with hematoxylin and eosin staining revealed characteristic aggregates of small blue cell tumor morphology in all cases. CK20 staining was absent in three cases and focally positive in two, defined as less than 5% of tumor cells. All cases demonstrated pancytokeratin (PanCK) positivity in the paranuclear dot-like pattern. Thyroid transcription factor 1 (TTF-1) was negative in all instances, supporting the diagnosis of MCC. This case series illustrates the diagnostic value and limitations of PanCK and TTF-1 staining in MCC in cases where CK20 is negative and discusses strategies for diagnosing this rare variant of MCC.

默克尔细胞癌(MCC)是一种罕见的侵袭性皮肤神经内分泌癌。MCC的诊断具有挑战性,特别是在细胞角蛋白20 (CK20)阴性或局部阳性的情况下。ck20阴性MCC约占MCC的5%。本病例系列描述了一个学术医疗中心的5例ck20阴性或局灶阳性MCC。所有病例均行皮肤病变活检。苏木精和伊红染色的组织病理学检查显示,所有病例都有特征性的小蓝细胞肿瘤形态聚集。3例未见CK20染色,2例局灶性阳性,定义为少于5%的肿瘤细胞。所有病例均表现为全细胞角蛋白(pancytokeratin, PanCK)阳性,呈核旁点状。甲状腺转录因子1 (TTF-1)在所有病例中呈阴性,支持MCC的诊断。本病例系列说明了在CK20阴性的MCC病例中,PanCK和TTF-1染色的诊断价值和局限性,并讨论了诊断这种罕见的MCC变异的策略。
{"title":"Cytokeratin 20-Negative Merkel Cell Carcinoma: A Case Series and Discussion of Diagnostic Strategies.","authors":"Ryan H Wealther, Kritin K Verma, Ethan Matthew, Helen Chen, Cloyce Stetson","doi":"10.1155/crdm/8439328","DOIUrl":"10.1155/crdm/8439328","url":null,"abstract":"<p><p>Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine carcinoma of the skin. MCC can present a diagnostic challenge, especially in cases where Cytokeratin 20 (CK20) is negative or focally positive. CK20-negative MCC accounts for about 5% of MCCs. This case series describes five cases of CK20-negative or focally positive MCC at an academic medical center. All cases were biopsies of cutaneous lesions. Histopathological investigation with hematoxylin and eosin staining revealed characteristic aggregates of small blue cell tumor morphology in all cases. CK20 staining was absent in three cases and focally positive in two, defined as less than 5% of tumor cells. All cases demonstrated pancytokeratin (PanCK) positivity in the paranuclear dot-like pattern. Thyroid transcription factor 1 (TTF-1) was negative in all instances, supporting the diagnosis of MCC. This case series illustrates the diagnostic value and limitations of PanCK and TTF-1 staining in MCC in cases where CK20 is negative and discusses strategies for diagnosing this rare variant of MCC.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2025 ","pages":"8439328"},"PeriodicalIF":0.0,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145862256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eyelid Phenol Peeling as a Potential Alternative to Surgical Blepharoplasty: A Case Series. 眼睑酚脱皮作为外科眼睑成形术的潜在替代方案:一个案例系列。
Q3 Medicine Pub Date : 2025-12-29 eCollection Date: 2025-01-01 DOI: 10.1155/crdm/7020601
Jana Dib El Jalbout, Caroline Silva Pereira, Maiara Onetta da Silva, Mariana Vilhena Ferreira, Nancy Emmanuel, Nelson Maurício Júnior, Roberto Tulli, Ivan Rollemberg

Phenol peel is a deep peel used to treat conditions involving the reticular dermis such as scars, deep wrinkles, and lentigos and is an attractive alternative to surgical interventions for the rejuvenation of the eyelids and face. Patients who wish to undergo this procedure should be screened for the presence of any contraindications and should be counseled on the possible complications, which include arrhythmia, skin atrophy, scarring, acne eruption, and infection. We describe the cases of four women who underwent deep phenol peeling for the improvement of wrinkles and aging features around the eyelid area as a conservative alternative to surgical blepharoplasty. Patients were previously healthy with no absolute contraindication for the procedure. They were instructed to use the Kligman formula for 1 month prior to peeling. A nonsteroidal anti-inflammatory medication was given to the patient 30 mins before starting the procedure. The skin was cleansed with urea foam for 1 min, and excess product was removed with a dry and then a moistened gauze until the skin was clean. A 70% alcohol solution was then used to clean the skin area in which the peeling was desired. Phenol concentrated at 88% was applied using a damp cotton swab over multiple layers, until peeling was achieved. At the end of the procedure, a plastic occlusive mask was used to seal the area, and a postphenol occlusive ointment was applied over the periorbital region. Patients were instructed not to wash the area for 7-10 days and were prescribed Hyabak eye drops for dryness as well as oral analgesics as needed. No complications were reported in all cases. Phenol peeling is an easy, relatively safe and effective deep peeling technique that can be used to achieve the desired aesthetic outcomes in patients who wish to improve aging features and minimize the appearance of deep wrinkles without undergoing surgical intervention.

苯酚去皮是一种深层去皮,用于治疗网状真皮层的病变,如疤痕、深度皱纹和斑痣,是眼睑和面部恢复活力的一种有吸引力的替代手术干预。希望接受此手术的患者应筛查是否存在任何禁忌症,并应告知可能的并发症,包括心律失常,皮肤萎缩,疤痕,痤疮爆发和感染。我们描述的情况下,四名妇女接受深层苯酚脱皮改善皱纹和老化特征周围的眼睑区域作为一个保守的替代手术眼睑成形术。患者既往健康,无手术绝对禁忌症。他们被指示在去皮前1个月使用克利格曼配方。在手术开始前30分钟给予患者非甾体抗炎药。用尿素泡沫清洁皮肤1分钟,用干燥纱布去除多余的产品,然后用湿润纱布擦拭皮肤,直到皮肤完全清洁。然后用70%的酒精溶液清洁想要去皮的皮肤区域。用湿棉签将浓度为88%的苯酚涂抹在多层上,直到达到剥落。在手术结束时,使用塑料闭塞口罩密封该区域,并在眶周区域涂上酚后闭塞软膏。患者被告知7-10天内不要清洗该区域,并开Hyabak眼药水治疗干燥,并根据需要口服止痛药。所有病例均无并发症。苯酚脱皮是一种简单、相对安全、有效的深度脱皮技术,对于那些希望改善衰老特征、减少深度皱纹的患者来说,它可以达到理想的美学效果,而无需进行手术干预。
{"title":"Eyelid Phenol Peeling as a Potential Alternative to Surgical Blepharoplasty: A Case Series.","authors":"Jana Dib El Jalbout, Caroline Silva Pereira, Maiara Onetta da Silva, Mariana Vilhena Ferreira, Nancy Emmanuel, Nelson Maurício Júnior, Roberto Tulli, Ivan Rollemberg","doi":"10.1155/crdm/7020601","DOIUrl":"10.1155/crdm/7020601","url":null,"abstract":"<p><p>Phenol peel is a deep peel used to treat conditions involving the reticular dermis such as scars, deep wrinkles, and lentigos and is an attractive alternative to surgical interventions for the rejuvenation of the eyelids and face. Patients who wish to undergo this procedure should be screened for the presence of any contraindications and should be counseled on the possible complications, which include arrhythmia, skin atrophy, scarring, acne eruption, and infection. We describe the cases of four women who underwent deep phenol peeling for the improvement of wrinkles and aging features around the eyelid area as a conservative alternative to surgical blepharoplasty. Patients were previously healthy with no absolute contraindication for the procedure. They were instructed to use the Kligman formula for 1 month prior to peeling. A nonsteroidal anti-inflammatory medication was given to the patient 30 mins before starting the procedure. The skin was cleansed with urea foam for 1 min, and excess product was removed with a dry and then a moistened gauze until the skin was clean. A 70% alcohol solution was then used to clean the skin area in which the peeling was desired. Phenol concentrated at 88% was applied using a damp cotton swab over multiple layers, until peeling was achieved. At the end of the procedure, a plastic occlusive mask was used to seal the area, and a postphenol occlusive ointment was applied over the periorbital region. Patients were instructed not to wash the area for 7-10 days and were prescribed Hyabak eye drops for dryness as well as oral analgesics as needed. No complications were reported in all cases. Phenol peeling is an easy, relatively safe and effective deep peeling technique that can be used to achieve the desired aesthetic outcomes in patients who wish to improve aging features and minimize the appearance of deep wrinkles without undergoing surgical intervention.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2025 ","pages":"7020601"},"PeriodicalIF":0.0,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12746350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145862265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Treatment of Upper Limb Superficial Lymphatic Malformation With Topical Sirolimus. 局部西罗莫司成功治疗上肢浅淋巴畸形。
Q3 Medicine Pub Date : 2025-12-26 eCollection Date: 2025-01-01 DOI: 10.1155/crdm/9574261
Bahareh Abtahi-Naeini, Sara Adibfard, AliMohammad Sabzghabaee, Raha Moradi Gharibvand

Lymphatic malformation (LM) is a congenital anomaly of the lymphatic system that can affect various anatomical sites, most commonly skin and subcutaneous tissues. Treatments that were historically used, including surgery, laser therapy (pulsed dye laser [PDL] and CO2 laser), and sclerotherapy, can be associated with complications such as bleeding and lesion recurrence. Oral sirolimus is effective in treating LMs but can be associated with systemic side effects, including immunosuppression and metabolic disturbances. Targeting the mTOR pathway, topical sirolimus effectively treats superficial LMs with minimal adverse effects compared to systemic administration. Several studies have reported that topical sirolimus shows comparable outcomes with minimal side effects. We present the case of a 19-year-old woman with bleeding from a superficial LM on the lateral aspect of her upper limb. Previous treatments, including carbon dioxide laser therapy and PDL, were ineffective. Within 3 months after initiating 0.1% topical sirolimus application twice daily, a noticeable reduction in lesion size and bleeding was observed, with no adverse effect.

淋巴畸形(LM)是一种先天性淋巴系统异常,可影响各种解剖部位,最常见的是皮肤和皮下组织。历史上使用的治疗方法,包括手术、激光治疗(脉冲染料激光[PDL]和CO2激光)和硬化治疗,可能与出血和病变复发等并发症相关。口服西罗莫司对治疗LMs有效,但可能伴有全身副作用,包括免疫抑制和代谢紊乱。针对mTOR通路,局部西罗莫司有效治疗浅表LMs,与全身给药相比,副作用最小。几项研究报道,局部西罗莫司显示出类似的结果,副作用最小。我们提出的情况下,19岁的女性与出血从浅表LM在她的上肢外侧。以前的治疗,包括二氧化碳激光治疗和PDL,都是无效的。在开始每日两次的0.1%局部西罗莫司应用后的3个月内,观察到病变大小和出血明显减少,无不良反应。
{"title":"Successful Treatment of Upper Limb Superficial Lymphatic Malformation With Topical Sirolimus.","authors":"Bahareh Abtahi-Naeini, Sara Adibfard, AliMohammad Sabzghabaee, Raha Moradi Gharibvand","doi":"10.1155/crdm/9574261","DOIUrl":"10.1155/crdm/9574261","url":null,"abstract":"<p><p>Lymphatic malformation (LM) is a congenital anomaly of the lymphatic system that can affect various anatomical sites, most commonly skin and subcutaneous tissues. Treatments that were historically used, including surgery, laser therapy (pulsed dye laser [PDL] and CO2 laser), and sclerotherapy, can be associated with complications such as bleeding and lesion recurrence. Oral sirolimus is effective in treating LMs but can be associated with systemic side effects, including immunosuppression and metabolic disturbances. Targeting the mTOR pathway, topical sirolimus effectively treats superficial LMs with minimal adverse effects compared to systemic administration. Several studies have reported that topical sirolimus shows comparable outcomes with minimal side effects. We present the case of a 19-year-old woman with bleeding from a superficial LM on the lateral aspect of her upper limb. Previous treatments, including carbon dioxide laser therapy and PDL, were ineffective. Within 3 months after initiating 0.1% topical sirolimus application twice daily, a noticeable reduction in lesion size and bleeding was observed, with no adverse effect.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2025 ","pages":"9574261"},"PeriodicalIF":0.0,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12742332/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145848939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-Induced Phototoxicity in Vitiligo: The Role of Hydrochlorothiazide in Photosensitivity Dermatitis. 白癜风药物诱导的光毒性:氢氯噻嗪在光敏性皮炎中的作用。
Q3 Medicine Pub Date : 2025-12-26 eCollection Date: 2025-01-01 DOI: 10.1155/crdm/4302190
Andres D Parga, Celina Dubin, Donald Rudikoff

Photosensitivity dermatitis is a multifactorial dermatologic condition characterized by an exaggerated cutaneous response to ultraviolet (UV) radiation, often exacerbated by exogenous agents, particularly photosensitizing medications. The pathophysiology involves direct phototoxic or immune-mediated photoallergic mechanisms, leading to inflammatory skin reactions upon UV exposure. In individuals with vitiligo, the absence of melanocytes in depigmented areas significantly diminishes photoprotective mechanisms, rendering these regions highly susceptible to UV-induced damage. Consequently, vitiliginous skin is inherently more vulnerable to photo-induced inflammation and cutaneous injury. We report a 54-year-old man with generalized vitiligo who developed erythematous papules confined to sun-exposed depigmented skin. The clinical course suggested a medication-induced phototoxic reaction, likely potentiated by the patient's underlying lack of cutaneous melanin. This case highlights the need to recognize drug-induced photosensitivity in vitiligo and understand how UV vulnerability and photosensitizing medications interact.

光敏性皮炎是一种多因素皮肤病,以皮肤对紫外线(UV)辐射的过度反应为特征,外源性药物,特别是光敏性药物,往往会加剧这种反应。病理生理学涉及直接的光毒性或免疫介导的光过敏机制,导致紫外线暴露后皮肤炎症反应。在患有白癜风的个体中,黑色素细胞在脱色区域的缺乏显着降低了光保护机制,使这些区域极易受到紫外线诱导的损伤。因此,白癜风皮肤天生更容易受到光诱导的炎症和皮肤损伤。我们报告一个54岁的男性与广泛性白癜风谁发展的红斑丘疹局限于太阳暴露脱色皮肤。临床过程提示药物引起的光毒性反应,可能由于患者潜在的皮肤黑色素缺乏而增强。该病例强调了认识白癜风中药物引起的光敏性以及了解紫外线易感性和光敏性药物如何相互作用的必要性。
{"title":"Drug-Induced Phototoxicity in Vitiligo: The Role of Hydrochlorothiazide in Photosensitivity Dermatitis.","authors":"Andres D Parga, Celina Dubin, Donald Rudikoff","doi":"10.1155/crdm/4302190","DOIUrl":"10.1155/crdm/4302190","url":null,"abstract":"<p><p>Photosensitivity dermatitis is a multifactorial dermatologic condition characterized by an exaggerated cutaneous response to ultraviolet (UV) radiation, often exacerbated by exogenous agents, particularly photosensitizing medications. The pathophysiology involves direct phototoxic or immune-mediated photoallergic mechanisms, leading to inflammatory skin reactions upon UV exposure. In individuals with vitiligo, the absence of melanocytes in depigmented areas significantly diminishes photoprotective mechanisms, rendering these regions highly susceptible to UV-induced damage. Consequently, vitiliginous skin is inherently more vulnerable to photo-induced inflammation and cutaneous injury. We report a 54-year-old man with generalized vitiligo who developed erythematous papules confined to sun-exposed depigmented skin. The clinical course suggested a medication-induced phototoxic reaction, likely potentiated by the patient's underlying lack of cutaneous melanin. This case highlights the need to recognize drug-induced photosensitivity in vitiligo and understand how UV vulnerability and photosensitizing medications interact.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2025 ","pages":"4302190"},"PeriodicalIF":0.0,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145848976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Case Reports in Dermatological Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1